Placenta-Derived Stem Cells and Their Effects on Breast Cancer Cells
Author Information
Author(s): Basmaeil Yasser, Al Subayyil Abdullah, Kulayb Haya Bin, Kondkar Altaf A., Alrodayyan Maha, Khatlani Tanvir, Kalyuzhny Alexander E.
Primary Institution: King Abdullah International Medical Research Center (KAIMRC), King Saud Bin Abdulaziz University for Health Sciences
Hypothesis
Can placenta-derived decidua basalis mesenchymal stem cells (DBMSCs) inhibit the epithelial-to-mesenchymal transition (EMT) in breast cancer cell lines?
Conclusion
DBMSCs can inhibit EMT-related proteins and reduce the invasive characteristics of breast cancer cells.
Supporting Evidence
- DBMSCs significantly reduced the functionality of MDA231 and MCF7 cells.
- DBMSC treatment decreased EMT-related protein levels in MDA231 cells.
- Co-culturing with cancer cells modulated the expression of anti-apoptotic genes in DBMSCs.
- DBMSCs inhibited the migration and invasion potential of breast cancer cells.
Takeaway
Scientists studied special cells from the placenta to see if they can help stop breast cancer cells from spreading. They found that these cells can make the cancer cells less aggressive.
Methodology
The study involved co-culturing DBMSCs with breast cancer cell lines and analyzing changes in their functions and gene expression.
Potential Biases
Potential bias in the selection of cell lines and the experimental conditions used.
Limitations
The study was conducted in vitro, and results may not fully translate to in vivo conditions.
Participant Demographics
Twenty healthy pregnant women provided placentas for the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website